On Thursday, Germany’s regulatory institute for vaccines stated that there are chances that the COVID-19 vaccine can be ready for its final tests by the end of this year.
President of the Paul-Ehrlich-Institut Professor Klaus Cichutek said that he is quite hopeful that the ongoing vaccine research projects in Germany will achieve development in the coming months.
According to him, by autumn a vaccine candidate will be ready for the final trials during which its effectiveness and safety will be estimated before approving it to be used by the public.
The president says that if these clinical trials prove successful, then by the end of the year or by the start of the next year they will proceed over towards the approval procedure.
A German biotechnology company BioNTech in April started testing some possible virus vaccines on few human volunteers after receiving authorization from the Paul-Ehrlich-Institut.
The professor also said that there are three more research centers in Germany that are about to begin clinical trials over their vaccine candidates.
All over the globe, scientists and researchers are trying to find out the vaccine for the deadly disease which originated from China last December and had up till now infected 4.38 million people and killed 298,000 globally.
Currently, the health experts are treating all patients with anti-malaria drug, hydroxychloroquine, and chloroquine. These drugs have so far shown positive results for coronavirus.